Carroll Financial Associates’s NuVasive, Inc. NUVA Stock Holding History

Carroll Financial Associates’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-27	Closed	-$1K	–	1890
2021 Q1	$1K	Buy	27 +9	+50%	+$540	﹤0.01%	1604
2020 Q4	$1K	Hold	18	–	–	﹤0.01%	1499
2020 Q3	$0	Hold	18	–	–	﹤0.01%	1739
2020 Q2	$1K	Hold	18	–	–	﹤0.01%	1482
2020 Q1	$0	Sell	18 -3,309	-99%	-$222K	﹤0.01%	1740
2019 Q4	$257K	Buy	3,327 +3,303	+13,763%	+$233K	0.02%	306
2019 Q3	$1K	Sell	24 -47	-66%	-$2.94K	﹤0.01%	1476
2019 Q2	$4K	Hold	71	–	–	﹤0.01%	1284
2019 Q1	$4K	Buy	71 +43	+154%	+$2.29K	﹤0.01%	1186
2018 Q4	$1K	Hold	28	–	–	﹤0.01%	1273
2018 Q3	$1K	Buy	28 +8	+40%	+$509	﹤0.01%	1289
2018 Q2	$1K	Buy	+20	New	+$1.05K	﹤0.01%	1245

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carroll Financial Associates's NUVA Position: Q2 2021 in Review

Carroll Financial Associates sold out of NuVasive, Inc. (NUVA) in Q2 2021, closing a stake of 27 shares — an estimated $1K sold.

Carroll Financial Associates first reported a position in NUVA in Q2 2018 and held it in 12 quarters. The position peaked at $257K in Q4 2019. 259 funds tracked by Wall St. Rank hold NUVA as of Q2 2021.

Carroll Financial Associates reported no remaining NuVasive, Inc. position as of Q2 2021 after selling out during the quarter.
Carroll Financial Associates sold 27 NuVasive, Inc. shares in Q2 2021, an estimated $1K.
Carroll Financial Associates first reported a position in NuVasive, Inc. in Q2 2018 and held it in 12 quarters.
Carroll Financial Associates's NuVasive, Inc. position peaked at $257K in Q4 2019.
259 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2021.

Based on Carroll Financial Associates's 13F filing for Q2 2021, filed 13 Jul 2021.